USPTO trademark

BRYNOVIN

RegisteredUSPTOWord markClass 5

"BRYNOVIN" is a word mark owned by Azurity Pharmaceuticals, Inc., filed at the USPTO on May 23, 2023. It is registered and covers class 5 (Pharmaceuticals).

Official USPTO record
BRYNOVIN trademark as filed
As filed with the USPTO
Status
Registered
Since September 16, 2025
Filed
May 23, 2023
Registered
September 16, 2025
Expires
Not recorded
Application no.
98008966
Registration no.
7950846
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns BRYNOVIN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services BRYNOVIN is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Use amendment filed
  7. Teas statement of use received
  8. Notice of approval of extension request e-mailed
  9. Sou extension 2 granted
  10. Sou extension 2 filed

10 earlier steps on the official record.

FAQ

About BRYNOVIN

Who owns the trademark "BRYNOVIN"?

The USPTO trademark "BRYNOVIN" (application 98008966) is owned by Azurity Pharmaceuticals, Inc.

What is the status of "BRYNOVIN"?

Its status at the USPTO is: registered.

When was "BRYNOVIN" registered?

It was registered on September 16, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BRYNOVIN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2bc0-4379-73de-be9f-37e56d7b7c9d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bc0-4379-73de-be9f-37e56d7b7c9d",
  "object": "trademark",
  "mark_text": "BRYNOVIN",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98008966",
  "filing_date": "2023-05-23",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Azurity Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb725-e6a7-73db-81c8-7bbc8473b1bf"
    }
  ]
}